Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Singapore ExchangeASXASXCME GroupEuronext
SymbolOTCMKTS:SPXCFOTCMKTS:ASXFYASX:ASXCNSX:CMEOTCMKTS:EUXTF
Price Information
Current Price$7.92$56.21N/AN/A$106.75
52 Week RangeHoldSellN/AN/ABuy
MarketRank™
Overall Score0.60.40.90.50.6
Analysis Score0.00.00.00.00.0
Community Score2.92.12.02.72.8
Dividend Score0.00.00.80.00.0
Ownership Score0.00.01.70.00.0
Earnings & Valuation Score0.00.00.00.00.0
Analyst Ratings
Consensus RecommendationHoldSellN/AN/ABuy
Consensus Price TargetN/AN/AN/AN/AN/A
% Upside from Price TargetN/AN/AN/AN/AN/A
Trade Information
Market CapN/AN/AN/AN/AN/A
BetaN/AN/AN/AN/AN/A
Average Volume3,7957,632N/AN/A667
Sales & Book Value
Annual RevenueN/AN/A$1.06 billionN/AN/A
Price / SalesN/AN/A0.00N/AN/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/A13.59N/AN/A
Book ValueN/AN/AA$19.22 per shareN/AN/A
Price / BookN/AN/A0.00N/AN/A
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSN/AN/AA$2.53N/AN/A
Trailing P/E Ratio0.000.000.000.000.00
Forward P/E RatioN/AN/A
P/E GrowthN/AN/A6.33N/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AA$2.35N/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/A92.81%N/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A2.61%N/AN/A
Current RatioN/AN/A1.10%N/AN/A
Quick RatioN/AN/A0.15%N/AN/A
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees968737737N/A1,069
Shares OutstandingN/AN/A193.60 millionN/AN/A
Next Earnings DateN/AN/AN/AN/AN/A
OptionableNot OptionableNot OptionableNot OptionableOptionableNot Optionable
SourceHeadline
Celyad Oncology Appoints Dr. Charles Morris as Chief Medical OfficerCelyad Oncology Appoints Dr. Charles Morris as Chief Medical Officer
feeds.benzinga.com - April 19 at 1:26 AM
Financial investors decrease net long position in Euronext wheatFinancial investors decrease net long position in Euronext wheat
hellenicshippingnews.com - April 15 at 8:42 PM
Short Interest in Euronext (OTCMKTS:EUXTF) Declines By 50.0%Short Interest in Euronext (OTCMKTS:EUXTF) Declines By 50.0%
americanbankingnews.com - April 15 at 4:29 PM
Italy MPs seek autonomy for Milan bourse after Euronext takeoverItaly MPs seek autonomy for Milan bourse after Euronext takeover
finance.yahoo.com - April 14 at 1:43 PM
Alan Allman Associates lists on Euronext ParisAlan Allman Associates lists on Euronext Paris
next-finance.net - April 13 at 1:00 AM
Euronext: Attractively Priced, But The Rights Issue May Provide A Better Entry PointEuronext: Attractively Priced, But The Rights Issue May Provide A Better Entry Point
seekingalpha.com - April 10 at 12:08 PM
Euronext’s December volumes up 10.6% MoM in MarchEuronext’s December volumes up 10.6% MoM in March
leaprate.com - April 9 at 8:40 AM
Euronext Posts Solid FX Volume Jump in March 2021Euronext Posts Solid FX Volume Jump in March 2021
financemagnates.com - April 9 at 8:40 AM
Nyxoah Reports Full Year 2020 ResultsNyxoah Reports Full Year 2020 Results
financialpost.com - April 9 at 1:14 AM
LARGO, an Eco-Responsible French Player in Refurbished Devices, Launches Its Initial Public Offering on Euronext Growth ParisLARGO, an Eco-Responsible French Player in Refurbished Devices, Launches Its Initial Public Offering on Euronext Growth Paris
wallstreet-online.de - April 9 at 12:15 AM
Onxeo to Present New Preclinical Data at AACR 2021Onxeo to Present New Preclinical Data at AACR 2021
feeds.benzinga.com - April 8 at 1:20 PM
European B2B Wealthtech Allfunds Set to List on Euronext Amsterdam Stock ExchangeEuropean B2B Wealthtech Allfunds Set to List on Euronext Amsterdam Stock Exchange
crowdfundinsider.com - April 8 at 8:04 AM
Allfunds eyes Euronext Amsterdam IPOAllfunds eyes Euronext Amsterdam IPO
investmentweek.co.uk - April 7 at 7:51 AM
Allfunds eyes Euronext Amsterdam IPO in bid to secure diverse sources of fundingAllfunds eyes Euronext Amsterdam IPO in bid to secure diverse sources of funding
investmentweek.co.uk - April 7 at 7:51 AM
Allfunds to list on Euronext AmsterdamAllfunds to list on Euronext Amsterdam
finextra.com - April 7 at 7:51 AM
Greenberg Traurig Amsterdam Continues Strategic Growth and Adds Two ShareholdersGreenberg Traurig Amsterdam Continues Strategic Growth and Adds Two Shareholders
prweb.com - April 6 at 4:58 AM
AB Science announces the signing of an exclusive licensing agreement with the University of Chicago to conduct research for the prevention and treatment of Covid-19AB Science announces the signing of an exclusive licensing agreement with the University of Chicago to conduct research for the prevention and treatment of Covid-19
feeds.benzinga.com - April 6 at 1:59 AM
Euronext (OTCMKTS:EUXTF) Given Average Recommendation of "Buy" by BrokeragesEuronext (OTCMKTS:EUXTF) Given Average Recommendation of "Buy" by Brokerages
americanbankingnews.com - March 31 at 5:00 AM
Euronext (OTCMKTS:EUXTF) Sees Large Decrease in Short InterestEuronext (OTCMKTS:EUXTF) Sees Large Decrease in Short Interest
americanbankingnews.com - March 30 at 3:06 PM
Transfer of GECI International shares to the Euronext Growth marketTransfer of GECI International shares to the Euronext Growth market
actusnews.com - March 26 at 5:37 AM
Fintech-focused SPAC EFIC1 to begin trading on Euronext AmsterdamFintech-focused SPAC EFIC1 to begin trading on Euronext Amsterdam
reuters.com - March 26 at 5:37 AM
Euronext wheatEuronext wheat
brecorder.com - March 26 at 12:37 AM
GECI INTERNATIONAL: Transfer of GECI International shares to the Euronext Growth marketGECI INTERNATIONAL: Transfer of GECI International shares to the Euronext Growth market
finanznachrichten.de - March 25 at 4:14 AM
Norsk Solar announces contemplated private placement and intention to list on Euronext Growth OsloNorsk Solar announces contemplated private placement and intention to list on Euronext Growth Oslo
pv-magazine.com - March 24 at 7:49 AM
Euronext wheat reboundsEuronext wheat rebounds
brecorder.com - March 23 at 8:39 PM
DateCompanyBrokerageAction
9/17/2020Singapore ExchangeThe Goldman Sachs GroupUpgrade
5/27/2020Singapore ExchangeCredit Suisse GroupDowngrade
10/25/2019Singapore ExchangeJPMorgan Chase & Co.Upgrade
2/15/2019ASXDeutsche Bank AktiengesellschaftDowngrade
12/14/2020EuronextKeefe, Bruyette & WoodsUpgrade
10/12/2020EuronextUBS GroupReiterated Rating
8/18/2020EuronextMorgan StanleyReiterated Rating
8/5/2020EuronextING GroupDowngrade
8/3/2020EuronextBarclaysDowngrade
4/2/2020EuronextCommerzbankDowngrade
3/12/2020EuronextHSBCUpgrade
1/13/2020EuronextJefferies Financial GroupInitiated Coverage
11/1/2019EuronextCitigroupUpgrade
(Data available from 4/20/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.